Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sullivan

Showing results (1101-1110 of 1,317) with videos related to

Pageof 132
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 2013
MicroRNA-155 tunes both the threshold and extent of NK cell activation via targeting of multiple signaling pathwaysRyan P Sullivan, Leslie A Fogel, Jeffrey W Leong, et al.
Journal of Environmental Management|May 19, 2020
Pulsed electric field application reduces carbapenem- and colistin-resistant microbiota and bla<sub>KPC</sub> spread in urban wastewaterGregory A Ballash, Seungjun Lee, Dixie F Mollenkopf, et al.
Acta Neuropathologica|January 29, 2000
Schwann cell-onion bulb tumor of the trigeminal nerve: hyperplasia, dysplasia or neoplasia?S F LaPoint, J M Powers, J M Woodruff, et al.
Sleep|October 2, 2012
Learning to live on a Mars day: fatigue countermeasures during the Phoenix Mars Lander missionLaura K Barger, Jason P Sullivan, Andrea S Vincent, et al.
Science Immunology|December 16, 2022
Myeloid cell-derived proteases produce a proinflammatory form of IL-37 that signals via IL-36 receptor engagementGraeme P Sullivan, Pavel Davidovich, Natalia Muñoz-Wolf, et al.
Science Advances|November 15, 2017
Pushing the limits of photoreception in twilight conditions: The rod-like cone retina of the deep-sea pearlsidesFanny de Busserolles, Fabio Cortesi, Jon Vidar Helvik, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 20, 2005
A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in ratsPrisca Honore, Carol T Wismer, Joe Mikusa, et al.
Science (New York, N.Y.)|January 10, 2006
Variability in nocturnal nitrogen oxide processing and its role in regional air qualityS S Brown, T B Ryerson, A G Wollny, et al.
Nature Communications|February 27, 2026
Obsidian forms by slow coolingE W Llewellin, F B Wadsworth, P Sullivan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2015
PTEN regulates natural killer cell trafficking in vivoJeffrey W Leong, Stephanie E Schneider, Ryan P Sullivan, et al.
Pageof 132

Showing results (1101-1110 of 1,317) with videos related to

Sort By:
Pageof 132
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 2013
MicroRNA-155 tunes both the threshold and extent of NK cell activation via targeting of multiple signaling pathwaysRyan P Sullivan, Leslie A Fogel, Jeffrey W Leong, et al.
Journal of Environmental Management|May 19, 2020
Pulsed electric field application reduces carbapenem- and colistin-resistant microbiota and bla<sub>KPC</sub> spread in urban wastewaterGregory A Ballash, Seungjun Lee, Dixie F Mollenkopf, et al.
Acta Neuropathologica|January 29, 2000
Schwann cell-onion bulb tumor of the trigeminal nerve: hyperplasia, dysplasia or neoplasia?S F LaPoint, J M Powers, J M Woodruff, et al.
Sleep|October 2, 2012
Learning to live on a Mars day: fatigue countermeasures during the Phoenix Mars Lander missionLaura K Barger, Jason P Sullivan, Andrea S Vincent, et al.
Science Immunology|December 16, 2022
Myeloid cell-derived proteases produce a proinflammatory form of IL-37 that signals via IL-36 receptor engagementGraeme P Sullivan, Pavel Davidovich, Natalia Muñoz-Wolf, et al.
Science Advances|November 15, 2017
Pushing the limits of photoreception in twilight conditions: The rod-like cone retina of the deep-sea pearlsidesFanny de Busserolles, Fabio Cortesi, Jon Vidar Helvik, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 20, 2005
A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in ratsPrisca Honore, Carol T Wismer, Joe Mikusa, et al.
Science (New York, N.Y.)|January 10, 2006
Variability in nocturnal nitrogen oxide processing and its role in regional air qualityS S Brown, T B Ryerson, A G Wollny, et al.
Nature Communications|February 27, 2026
Obsidian forms by slow coolingE W Llewellin, F B Wadsworth, P Sullivan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2015
PTEN regulates natural killer cell trafficking in vivoJeffrey W Leong, Stephanie E Schneider, Ryan P Sullivan, et al.
Pageof 132